- Home
- ROP vs TAK Comparison
ROP vs TAK Comparison
Compare ROP & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROP
- TAK
- Stock Information
- Founded
- ROP 1981
- TAK 1781
- Country
- ROP United States
- TAK Japan
- Employees
- ROP N/A
- TAK N/A
- Industry
- ROP Industrial Machinery/Components
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- ROP Industrials
- TAK Health Care
- Exchange
- ROP Nasdaq
- TAK Nasdaq
- Market Cap
- ROP 58.3B
- TAK 47.3B
- IPO Year
- ROP 1992
- TAK N/A
- Fundamental
- Price
- ROP $518.44
- TAK $15.41
- Analyst Decision
- ROP Buy
- TAK
- Analyst Count
- ROP 12
- TAK 0
- Target Price
- ROP $633.18
- TAK N/A
- AVG Volume (30 Days)
- ROP 764.3K
- TAK 2.8M
- Earning Date
- ROP 10-22-2025
- TAK 10-30-2025
- Dividend Yield
- ROP 0.64%
- TAK 3.53%
- EPS Growth
- ROP 5.46
- TAK N/A
- EPS
- ROP 14.24
- TAK 0.59
- Revenue
- ROP $7,468,100,000.00
- TAK $31,053,301,865.00
- Revenue This Year
- ROP $13.79
- TAK $0.40
- Revenue Next Year
- ROP $8.34
- TAK $0.83
- P/E Ratio
- ROP $36.41
- TAK $51.22
- Revenue Growth
- ROP 13.59
- TAK 1.52
- 52 Week Low
- ROP $499.47
- TAK $12.80
- 52 Week High
- ROP $595.17
- TAK $15.56
- Technical
- Relative Strength Index (RSI)
- ROP 39.58
- TAK 62.30
- Support Level
- ROP $516.25
- TAK $14.90
- Resistance Level
- ROP $532.18
- TAK $15.23
- Average True Range (ATR)
- ROP 8.30
- TAK 0.13
- MACD
- ROP 0.08
- TAK 0.02
- Stochastic Oscillator
- ROP 7.63
- TAK 80.77
About ROP Roper Technologies Inc.
Roper Technologies is a holding company focused on acquiring, managing, and developing niche market-leading technology businesses. The company operates a decentralized business model whereby each portfolio company operates independently from the others. Roper positions itself as a free cash flow compounder, whereby excess free cash flow generated by its portfolio businesses is repatriated to the parent company, which is then utilized to acquire additional businesses. Presently, the company operates 30 distinct businesses with over three-fourths of the revenue coming from software products and over two-thirds of revenue coming from recurring and reoccurring sources.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.